← Back to Library
NeoBenz® Micro 3.5%
and 5.5% creams,
NeoBenz
® Micro SD 5.5% single dose cream and NeoBenz® Micro
Wash 7% are topical preparations containing benzoyl peroxide as the active
ingredient incorporated into patented porous microspheres (
MICROSPONGE
®*
delivery system) composed of methyl methacrylate/glycol dimethacrylate
crosspolymer. This polymeric system has been shown to provide gradual release
of active ingredient into the skin1 and absorb natural skin oils2.
Ingredients for all cream and SD strengths include: water, glycerin, ethylhexyl
palmitate, sorbitol, cetyl alcohol, glyceryl ditaurate, stealryl alcohol,
magnesium aluminum silicate, methyl methacrylate/glycol dimethacrylate
crosspolymer, silica, citric acid, xanthan gum, methylparaben, sodium
citrate,
propyIparaben, polyacrylamide, C13-14 isoparaffin, laureth-7, sodium
lauryl sulfate. Ingredients for the Wash include citric acid, cocamidopropyl
betaine, cocamine oxide, disodium laureth sulfosuccinate, edetate disodium,
fragrance, glycerin, hydrogenated castor oil, hypromellose, magnesium aluminum
silicate, methyl methacrylate/Glycol dimethacrylate crosspolymer,
methylparaben, PEG-150 pentaerythrityl tetrastearate (and) PEG-6
caprylic/capric glycerides, PEG-40 hydrogenated castor oil, poloxamer 182,
purified water and xanthan gum.
Benzoyl peroxide is
an oxidizing agent that possesses antibacterial properties and is classified as
a keratolytic. Benzoyl peroxide (C14H10O4) is represented by the following
structure:
The exact method of
action of benzoyl peroxide in acne vulgaris is not known. Benzoyl peroxide is
an antibacterial agent with demonstrated activity against Propionibacterium
acnes. This action, combined with the mild keratolytic effect of benzoyl
peroxide is believed to be responsible for its usefulness in acne. Benzoyl
peroxide
is absorbed by the skin where
it
is metabolized to benzoic acid and
excreted as benzoate in the urine.
NeoBenz®
Micro,
NeoBenz®
Micro SD and NeoBenz®
Micro Wash are indicated for use in the topical treatment of mild to moderated acne vulgaris.
NeoBenz®
Micro,
NeoBenz®
Micro SD and NeoBenz®
Micro Wash should not be used in
patients who have shown hypersensitivity to benzoyl peroxide or to any of the
other ingredients in the products.
When using this
product, avoid unnecessary sun exposure and use a sunscreen.
(
SEE WARNINGS
)
General– For
external use only. Avoid contact with eyes and mucous membranes. If severe
irritation develops, discontinue use and institute appropriate therapy.
Avoid contact with eyes, eyelids, lips and mucous membranes. If
accidental contact occurs, rinse with water. AVOID CONTACT WITH HAIR, FABRICS
OR CARPETING AS BENZOYL PEROXIDE WILL CAUSE BLEACHING OR DISCOLORATION. If
excessive
irritation develops, discontinue use and consult your physician.
Based upon all available evidence,
benzoyl
peroxide
is not considered to be a carcinogen. However, data from a study using mice
known to be highly susceptible to cancer suggest that benzoyl peroxide acts as
a tumor promoter. The clinical significance of the findings is not known.
Category C
- Animal
reproduction
studies have not been conducted with benzoyl peroxide. It is also not
known whether benzoyl peroxide can cause fetal harm when administered to a
pregnant woman or can affect reproduction capacity. Benzoyl peroxide should be
used by a pregnant woman only if clearly needed.
Allergic contact
dermatitis and dryness have been reported with topical benzoyl peroxide
therapy.
If excessive scaling,
erythema or edema occurs, the use of these preparations should be discontinued.
To hasten resolution of the adverse effects, cool compresses may be used. After
symptoms and signs subside, a reduced dosage schedule may be cautiously tried if
the reaction is judged to be due to excessive use and not allergenicity.
NeoBenz®
Micro,
NeoBenz®
Micro SD and NeoBenz®
Micro Wash should be used once
or twice daily on the affected areas. Frequency of use should be adjusted to
obtain the desired clinical response. If yo
u see medication or white residue on skin after application of
NeoBenz®
Micro or
NeoBenz®
Micro
SD, you are applying too much. Gentle cleansing of the affected areas with a mild cleanser prior to application of NeoBenz®
Micro
or NeoBenz®
Micro
SD may be beneficial. Clinically visible improvement will normally occur by the third week if therapy. Maximum lesion reduction may be expected after approximately eight to twelve weeks for drug use. Continuing use of the drug us normally required to maintain a satisfactory clinical response.
NeoBenz®
Micro
: If applying to the entire face, apply a pea-sized amount of NeoBenz®
Micro to one fingertip and dab onto cheeks, forehead and chin. Spread evenly onto entire face.
NeoBenz®
Micro SD: Firmly squeeze applicator until seal between applicator and sponge has broken. Apply medication by rubbing sponge on small circular motions on affected areas. Dispose of each applicator after single use only.
NeoBenz®
Micro Wash: Shake well before using. Wet skin areas to be treated; apply NeoBenz®
Micro Wash by massaging gently into skin for 10-20 seconds, working into a full lather. Rinse thoroughly and pat dry.
SIZE: 45 gram tube
NDC NUMBER:
(3.5% benzoyl peroxide cream): 67402-020-45
(5.5% benzoyl peroxide cream): 67402-021-45
NeoBenz® Micro SD is supplied as follows:
SIZE: 1 box of thirty 0.5 gram applicators
NDC NUMBER:
(5.5% benzoyl peroxide cream): 67402-021-06
NeoBenz® Micro Wash is supplied as follows:
SIZE: 180 gram tottle
NDC NUMBER:
(benzoyl peroxide 7%): 67402-027-17
Store between 15o - 25o C (59o - 77o F)
2. Meyer R. Rosen (ed.), Delivery System Handbook for Personal care and Cosmetic Products, 332-352 (2005).
FDA LABEL
GENERIC: Benzoyl Peroxide MFR: SkinMedica Pharmaceuticals, Inc., Carlsbad, CA 92010
Neobenz Micro 70 Mg/ml Medicated Liquid Soap
Table of Contents
- I. DESCRIPTION
- II. CLINICAL PHARMACOLOGY
- III. INDICATIONS AND USAGE
- IV. CONTRAINDICATIONS
- V. WARNINGS
- VI. PRECAUTIONS
- PATIENT COUNSELING INFORMATION
- CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY
- USE IN SPECIFIC POPULATIONS
- VII . ADVERSE REACTIONS
- VIII. OVERDOSAGE
- IX. DOSAGE AND ADMINISTRATION
- X. HOW SUPPLIED
- REFERENCES
- NeoBenz Micro Wash, Benzoyl Peroxide 7%
NeoBenz
®
Micro
(benzoyl peroxide cream)
NeoBenz®
Micro SD
(benzoyl peroxide cream)
NeoBenz®
Micro Wash
(benzoyl peroxide)
Rx ONLY.
FOR EXTERNAL USE ONLY.
(benzoyl peroxide cream)
NeoBenz
(benzoyl peroxide cream)
NeoBenz
(benzoyl peroxide)
Rx ONLY.
FOR EXTERNAL USE ONLY.
I. DESCRIPTION
II. CLINICAL PHARMACOLOGY
III. INDICATIONS AND USAGE
IV. CONTRAINDICATIONS
V. WARNINGS
VI. PRECAUTIONS
General
PATIENT COUNSELING INFORMATION
Information for Patients:CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY
Carcinogenesis, Mutagenesis, Impairment of Fertility:USE IN SPECIFIC POPULATIONS
Pregnancy:
Nursing Mothers:
It
is not known whether this drug is excreted in human milk. Because many drugs
are
excreted in human milk, caution should be
exercised when benzoyl peroxide is administered to a nursing
woman.
Pediatric Use:
Safety
and effectiveness in children below the age of 12 have not been established.
VII . ADVERSE REACTIONS
VIII. OVERDOSAGE
IX. DOSAGE AND ADMINISTRATION
X. HOW SUPPLIED
NeoBenz® Micro is supplied as follows:SIZE: 45 gram tube
NDC NUMBER:
(3.5% benzoyl peroxide cream): 67402-020-45
(5.5% benzoyl peroxide cream): 67402-021-45
NeoBenz® Micro SD is supplied as follows:
SIZE: 1 box of thirty 0.5 gram applicators
NDC NUMBER:
(5.5% benzoyl peroxide cream): 67402-021-06
NeoBenz® Micro Wash is supplied as follows:
SIZE: 180 gram tottle
NDC NUMBER:
(benzoyl peroxide 7%): 67402-027-17
REFERENCES
1. Wester RC, Patel R, Nacht S, Leyden J, Melendres J, Maibach H. Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. J. Am. Acad. Dermatol. 1991;24; 720-726.2. Meyer R. Rosen (ed.), Delivery System Handbook for Personal care and Cosmetic Products, 332-352 (2005).
Distributed by SkinMedica Pharmaceuticals, Inc., Carlsbad. CA 92010
Covered by Us Patents: 4,690,825; 5,145,675; 5,879,716; 6,007,364.
*MICROSPONGE® is a registered trademark of AMCOL Health and Beauty Solutions, Inc, a subsidiary of AMCOL International Corporation.
129008 December 2008
P7001-03
Covered by Us Patents: 4,690,825; 5,145,675; 5,879,716; 6,007,364.
*MICROSPONGE® is a registered trademark of AMCOL Health and Beauty Solutions, Inc, a subsidiary of AMCOL International Corporation.
129008 December 2008
P7001-03